Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.

Am J Transplant 2005 Aug;5(8):2037-46

Diabetes Research Institute and Departments of Surgery and Radiology, University of Miami, Miami, FL, USA.

Following the success obtained with transplantation of fresh human islets under steroid-free immunosuppression, this trial evaluated the transplantation of islets that had undergone a period of in vitro culture and the potential of tumor necrosis factor (TNF-alpha) blockade to improve islet engraftment. Subjects included 16 patients with type 1 diabetes mellitus (T1DM); half were randomly assigned to receive Infliximab immediately preceding initial infusion. Immunosuppression consisted of daclizumab induction and sirolimus/tacrolimus maintenance. Out of 16 subjects 14 achieved insulin independence with one or two islet infusions; adverse events precluded completion in two. Without supplemental infusions, 11/14 (79%) subjects were insulin independent at 1 year, 6/14 (43%) at 18 months; these same subjects remain insulin independent at 33+/-6 months. While on immunosuppression, all patients maintained graft function. Out of 14 patients, 8 suffered chronic partial graft loss, likely immunological in nature, 5 of these received supplemental infusions. Currently, 11 subjects remain on immunosuppression, 8 (73%) are insulin independent, two with supplemental infusions. Insulin independent subjects demonstrated normalization of HbA1c, fructosamine and Mean Amplitude of Glycemic Excursions (MAGE) values. No clinical benefit of infliximab was identified. These results demonstrate that transplantation of cultured human islet allografts results in reproducible insulin independence in all subjects under this immunosuppressive regimen, comparable to that of freshly transplanted islets (Edmonton protocol).

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1600-6143.2005.00957.x
Publisher Site
http://dx.doi.org/10.1111/j.1600-6143.2005.00957.xDOI Listing
August 2005
19 Reads

Publication Analysis

Top Keywords

insulin independent
16
supplemental infusions
12
insulin independence
8
steroid-free immunosuppression
8
subjects remain
8
diabetes mellitus
8
islets steroid-free
8
type diabetes
8
subjects
7
insulin
6
immunosuppression
5
remain insulin
4
suffered chronic
4
independent 33+/-6
4
months subjects
4
partial graft
4
6/14 43%
4
43% months
4
chronic partial
4
months immunosuppression
4

References

(Supplied by CrossRef)

Ricordi C et al.
Diabetes 2003

Alejandro R et al.
Am J Transplant 2003

Hirshberg B et al.
Diabetes Care 2003

Ryan EA et al.
Diabetes 2001

Ryan EA et al.
Diabetes 2002

Similar Publications